Inventor · disambiguated record
Seongtae Yun
Also filed as: YUN SEONGTAE
8 granted patents·1 pending application·47 citations·filing 2008–2016
86Inventor score
Files withKOH DAEKYUNG5LEE KYUHYUN1MOGAM BIOTECH RES INST1MOGAM BIOTECHNOLOGY INST1MOGAM BIOTECHNOLOGY RES INSTITUTE1
Top patents by PatentIndex Score
9 records- 0191US9493745B2Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the sameMOGAM BIOTECH RES INST·Filed 2014·Granted Nov 15, 2016·10 cites·11 claims
- 0288US9018182B2Tumor specific promoter and oncolytic virus vector comprising the sameKOH DAEKYUNG·Filed 2010·Granted Apr 28, 2015·11 cites·12 claims
- 0386US8628956B2Expression vector suitable for expression of a coding sequence for gene therapyKOH DAEKYUNG·Filed 2012·Granted Jan 14, 2014·5 cites·19 claims
- 0484US10066215B2Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the sameMOGAM BIOTECHNOLOGY RES INSTITUTE·Filed 2016·Granted Sep 4, 2018·8 cites·18 claims
- 0584US8617875B2Expression vector suitable for expression of a coding sequence for gene therapyKOH DAEKYUNG·Filed 2012·Granted Dec 31, 2013·4 cites·19 claims
- 0684US8569051B2Expression vector for gene therapyKOH DAEKYUNG·Filed 2012·Granted Oct 29, 2013·4 cites·19 claims
- 0784US8309698B2Expression vector suitable for expression of a coding sequence for gene therapyKOH DAEKYUNG·Filed 2008·Granted Nov 13, 2012·5 cites·19 claims
- 0852US10301645B2Expression vector for expressing heterogeneous geneMOGAM BIOTECHNOLOGY INST·Filed 2014·Granted May 28, 2019·0 cites·13 claims
- 0950US2013058897A1Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the sameLEE KYUHYUN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seongtae Yun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →